Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Even if you you’re not diabetic or obese, can Ozempic be right for you? Ever since the weekly injectable was approved in 2017 ...

New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

There is also a strong rationale provided to avoid use of sliding-scale insulin and to consider the use of oral agents and ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

In addition, the American Diabetes Association’s treatment guidelines recommend GLP-1 agonists (the drug class Ozempic and Victoza belong to) as a treatment option for adults with type 2 ...

Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...

These segments include drug class, diabetes type, route of administration, and distribution channels, each playing a critical role in addressing the varied needs of individuals managing diabetes.

November is National Diabetes Month, and the Food for Life plant-based nutrition and cooking class program is launching Wipe ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...